Acist Medical Systems has received FDA clearance for its Voyager Model E2000 contrast delivery system. Voyager is designed for use in conjunction with x-ray equipment to diagnose and treat vascular disease. The company plans to launch the Voyager system
Acist Medical Systems has received FDA clearance for its Voyager Model E2000 contrast delivery system. Voyager is designed for use in conjunction with x-ray equipment to diagnose and treat vascular disease. The company plans to launch the Voyager system in early April into the U.S. endovascular market. Voyager includes an automated syringe operated by a button-operated device called AngioTouch and a touchscreen display that lets the physician tailor injections at the patient’s side.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.